LV11784A - Fibrinspecifiska antiviela kas pielietojama ka antitrombotisks lidzeklis - Google Patents

Fibrinspecifiska antiviela kas pielietojama ka antitrombotisks lidzeklis

Info

Publication number
LV11784A
LV11784A LV960379A LV960379A LV11784A LV 11784 A LV11784 A LV 11784A LV 960379 A LV960379 A LV 960379A LV 960379 A LV960379 A LV 960379A LV 11784 A LV11784 A LV 11784A
Authority
LV
Latvia
Prior art keywords
specific antibody
antithrombotic agent
fibrin specific
fibrin
antithrombotic
Prior art date
Application number
LV960379A
Other languages
English (en)
Other versions
LV11784B (en
Inventor
Paul E Gargan
Original Assignee
American Biogenetic Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Biogenetic Sciences filed Critical American Biogenetic Sciences
Publication of LV11784A publication Critical patent/LV11784A/lv
Publication of LV11784B publication Critical patent/LV11784B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LVP-96-379A 1994-02-24 1996-09-23 Fibrin-specific antibody for use as an antithrombotic agent LV11784B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/204,015 US5487892A (en) 1994-02-24 1994-02-24 Method for treating thrombotic disease using a fibrin specific monoclonal antibody
PCT/US1995/001825 WO1995022986A1 (en) 1994-02-24 1995-02-21 Fibrin-specific antibody for use as an antithrombotic agent

Publications (2)

Publication Number Publication Date
LV11784A true LV11784A (lv) 1997-06-20
LV11784B LV11784B (en) 1997-12-20

Family

ID=22756260

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-96-379A LV11784B (en) 1994-02-24 1996-09-23 Fibrin-specific antibody for use as an antithrombotic agent

Country Status (26)

Country Link
US (1) US5487892A (lv)
EP (1) EP0749320A4 (lv)
JP (1) JPH09509429A (lv)
KR (1) KR970701063A (lv)
CN (1) CN1146157A (lv)
AU (1) AU708897B2 (lv)
BG (1) BG62476B1 (lv)
BR (1) BR9506949A (lv)
CA (1) CA2183953A1 (lv)
CZ (1) CZ246496A3 (lv)
FI (1) FI963288A0 (lv)
GE (1) GEP20002257B (lv)
HU (1) HUT76536A (lv)
LT (1) LT4192B (lv)
LV (1) LV11784B (lv)
MD (1) MD1521G2 (lv)
MX (1) MX9603602A (lv)
NO (1) NO963497L (lv)
NZ (1) NZ281481A (lv)
PL (1) PL316005A1 (lv)
RU (1) RU2152801C2 (lv)
SG (1) SG53279A1 (lv)
SK (1) SK108496A3 (lv)
TJ (1) TJ301B (lv)
UA (1) UA41984C2 (lv)
WO (1) WO1995022986A1 (lv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5453359A (en) * 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
US5817768A (en) * 1995-06-07 1998-10-06 The New York Blood Center, Inc. Monospecific antibodies against a subunit of fibrinogen
US6727102B1 (en) 1997-06-20 2004-04-27 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
IL134828A0 (en) * 2000-03-01 2001-05-20 Eship 4U Com Inc System for delivery and receipt of dispatches especially useful for e-commerce
US20050181451A1 (en) * 2004-02-12 2005-08-18 Bates Harold M. Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
EP1832654B1 (en) * 2004-12-28 2011-07-27 Sekisui Medical Co., Ltd. Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody
CA2831572C (en) 2011-05-02 2019-11-26 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
EP2885002A4 (en) 2012-08-14 2016-04-20 Ibc Pharmaceuticals Inc BISPECIFIC ANTIBODIES REDIRECTED AGAINST T CELLS FOR THE TREATMENT OF DISEASES
AU2013360335B2 (en) 2012-12-13 2017-12-07 Immunomedics, Inc. Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
CN110563258A (zh) * 2019-09-06 2019-12-13 广东石油化工学院 一种猪场废水厌氧产氢与达标排放处理方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572125B2 (en) * 1983-03-17 1988-05-05 Mabco Limited Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
JP2635343B2 (ja) * 1986-04-14 1997-07-30 ザ・ジェネラル・ホスピタル・コーポレーション ヘテロ二官能性抗体および利用方法
AU7912887A (en) * 1986-08-25 1988-03-24 American Biogenetic Sciences, Inc. Monoclonal antibodies to fibrin
DE3701812A1 (de) * 1987-01-22 1988-08-04 Max Planck Gesellschaft Fibrinspezifischer antikoerper, verfahren zur seiner herstellung und seine verwendung
US5120834A (en) * 1988-06-13 1992-06-09 American Biogenetic Sciences, Inc. Fibrin-specific monoclonal antibody
SG50681A1 (en) * 1988-06-13 1998-07-20 American Biogenetic Sciences Method for the production of monoclonal antibodies utilizing a germfree animal
US5223410A (en) * 1988-06-13 1993-06-29 American Biogenetic Sciences, Inc. Method for production of antibodies utilizing an antigen-free animal
US5091512A (en) * 1988-06-13 1992-02-25 American Biogenetic Sciences, Inc. Fibrinogen-specific monoclonal antibody
US5206140A (en) 1988-06-24 1993-04-27 Research Corporation Technologies, Inc. Assay for soluble crosslinked fibrin polymers
CA2052283A1 (en) * 1990-09-27 1992-03-28 Edgar Haber Recombinant hybrid immunoglobulin molecules and method of use

Also Published As

Publication number Publication date
SG53279A1 (en) 1998-09-28
HUT76536A (en) 1997-09-29
LT4192B (en) 1997-07-25
NZ281481A (en) 1998-07-28
MD1521G2 (ro) 2001-03-31
GEP20002257B (en) 2000-10-25
AU708897B2 (en) 1999-08-12
KR970701063A (ko) 1997-03-17
NO963497D0 (no) 1996-08-22
BG62476B1 (bg) 1999-12-30
US5487892A (en) 1996-01-30
CN1146157A (zh) 1997-03-26
FI963288A (fi) 1996-08-23
BG100863A (en) 1997-08-29
MX9603602A (es) 1997-05-31
NO963497L (no) 1996-10-16
RU2152801C2 (ru) 2000-07-20
PL316005A1 (en) 1996-12-23
FI963288A0 (fi) 1996-08-23
EP0749320A1 (en) 1996-12-27
AU1843495A (en) 1995-09-11
SK108496A3 (en) 1997-10-08
MD1521F2 (en) 2000-08-31
WO1995022986A1 (en) 1995-08-31
CA2183953A1 (en) 1995-08-31
BR9506949A (pt) 1997-09-23
LT96140A (en) 1997-03-25
JPH09509429A (ja) 1997-09-22
LV11784B (en) 1997-12-20
EP0749320A4 (en) 1997-06-18
CZ246496A3 (en) 1997-04-16
UA41984C2 (uk) 2001-10-15
TJ301B (en) 2001-08-06
MD960334A (en) 1997-09-30
HU9602337D0 (en) 1996-10-28

Similar Documents

Publication Publication Date Title
BR8902764A (pt) Composicao detergente liquida
DK330884A (da) Menstruationsbind
BR8904489A (pt) Composicao detergente
NO307150B1 (no) Tetning mellom to deler
DE69122358D1 (de) Emulator für Japanisch
DE69431570D1 (de) Positivarbeitende resistzusammensetzung
LV11784A (lv) Fibrinspecifiska antiviela kas pielietojama ka antitrombotisks lidzeklis
BR9000010A (pt) Composicao detergente liquida enzimatica
BR8906958A (pt) Composicao detergente
DK0776302T3 (da) Sammenkoblingsstykke
IT1177263B (it) Retinoidi
NO152382C (no) Fluidumakkumulator
DE69031848D1 (de) Fluorsiliconmassen mit verbessertem elastischen Verhalten
IT1240143B (it) Giunto elastico
BR8904490A (pt) Composicao detergente
KR860004644A (ko) 탈취장치
DE68925390D1 (de) Waschmittelzusammensetzung
BR8904319A (pt) Composicao elastomerica
FR2619009B1 (fr) Agent anti-hyperlipemique
BR9003861A (pt) Composicao catalitica bem como sua utilizacao
ATA218584A (de) Hydraulischer puffer
ATA377684A (de) Adsorptionsmittel
DK161976C (da) Phosphaterstatninger for vaske- og rengoeringsmidler
BR8606935A (pt) Simulador de oclusao
BR8904318A (pt) Composicao elastomerica